Abstract:
Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC3 activity.
Abstract:
Provided herein are compounds of Formulae (I) and (II), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the compounds or compositions disclosed herein for treating and/or preventing proliferative diseases, cancers, carcinoma lung cancer, breast cancer, liver cancer, pancreatic cancer, gastric cancer, ovarian cancer, colon cancer, colorectal cancer, leukemia, sarcoma and/or cardiovascular diseases in a subject in need thereof. In certain embodiments, the sarcoma is Ewing's sarcoma. Provided are methods of inhibiting a histone demethylase in a subject and/or in a cell, tissue, or biological sample. In certain embodiments, the histone demethylase is a KDM. In certain embodiments, the KDM is KDM5. In certain embodiments, the biological sample is a cell. In certain embodiments, the biological sample is a tissue.
Abstract:
A method for reducing NO x in a gas stream by sequentially exposing the gas stream to a first and a second catalyst. The first catalyst converts at least a portion of the gas stream to a reducing gas, it reduces at least a portion of the NO x in a first temperature range, and it absorbs at least a portion of the NO x in the temperature range. The second catalyst reduces at least a portion of the NO x in a second temperature range utilizing the reducing gas produced by the second catalyst. The reducing gas produced by the first catalyst is typically a partially oxidized hydrocarbon, preferably an aldehyde, and more preferably acetaldehyde or formaldehyde. In addition to the first and second catalysts, the gas stream may be exposed to a plasma. Preferably, the first catalyst is selected as a zeolite, and more preferably a zeolite impregnated with a cation. The cation is preferably selected from the group consisting of an alkaline cation, an alkaline earth cation, and combinations thereof and preferably exhibits pores sizes of greater than 4 angstroms, and more preferably exhibits pores sizes of greater than 7 angstroms. The second catalyst is preferably γ-alumina catalyst, and more preferably a γ-alumina catalyst impregnated with transition metals, including, but not limited to, Ag, In and Sn.
Abstract:
An exhaust aftertreatment system (14) including a housing (18, 218) with two or more inlets (230, 232) configured to receive separate entering exhaust streams from an engine (12). The system (14) may include two or more first exhaust treatment devices (262, 242), each configured to receive one of the separate entering exhaust streams in a first direction. The system may further include two or more redirecting flow passages (248, 254) configured to combine the separate exhaust streams into a merged exhaust stream that flows in a second direction about 180 degrees from the first direction and an intermediate flow region configured to divide the merged exhaust stream into two or more separate exiting exhaust streams. The system also may also includes two or more second exhaust treatment devices (280, 282), each configured to receive one of the separate exiting exhaust streams in a third direction about 90 degrees from the second direction.
Abstract:
In one aspect the invention relates to a method for testing a chemical entity for its capability to modulate a (poly)peptide that is malfunctioning by means of an interaction of said chemical entity and said (poly)peptide, the method using single- molecule force spectroscopy. In another aspect the invention relates to a method for testing a chemical or physical entity for its capability to interact with a G protein-coupled receptor (GPCR) in its natural membrane environment, the method using single-molecule force spectroscopy.
Abstract:
A system and method for treating exhaust gas are provided. The system (100) has a source of combustion exhaust (102), a first fluid passageway (114) and a second fluid passageway (116). The first fluid passageway directs combustion exhaust from the source into the atmosphere. The second fluid passageway directs combustion exhaust from the source back into the source. The system also has at least one sulfur-oxide-removing device (108). The sulfur-oxide-removing device is disposed within at least one of the first or second fluid passageways.
Abstract:
The invention provides a composition and method to enrich water with hydrogen to provide a fuel source for hydrogen energy. The composition is made with a method using silicon and silicon dioxide as a catalyst to form the hydrogen enriched water based fuel.
Abstract:
The invention provides a composition and method to enrich water with hydrogen to provide a fuel source for hydrogen energy. The composition is made with a method using silicon and silicon dioxide as a catalyst to form the hydrogen enriched water based fuel.
Abstract:
A method for purging reductant is disclosed. The method includes dispensing reductant into an exhaust system (12) via a dispensing device (65). The method also includes purging the dispensing device by urging the reductant from the dispensing device to a reductant source (35).